Markets
Plans Sign in
APP →

Intuitive Surgical (ISRG) stock

Stock · prices in USD

Next quarterly results

Estimated around Jan 21, 2027 (in 68 days)

Estimated from the company's previous report dates; the official date is announced by the company.

Is it growing?

Revenue from SEC filings · fiscal 2022–2025

Revenue growth per year (3 fiscal years)+17.4%
Latest quarter vs a year earlier+21.7%quarter ended Sep 30, 2026

Does it make money?

Margins, cash and debt from SEC filings

Net margin28.4%fiscal 2025 · range 21.3%–28.4% over 4 years
Operating margin29.3%fiscal 2025
Free cash flow, last 12 months$3.6Bto Sep 30, 2026
Diluted shares, 3-year change+0.2%
P/E (12 months)53.74 quarters to Sep 30, 2026
1-year and 5-year range in the app 

Price ÷ diluted earnings per share of the last 4 quarters to Sep 30, 2026 (SEC filing of Oct 21, 2026). Price as of Nov 14, 2026, 19:50 UTC. A descriptive ratio: it does not say whether a stock is worth buying, and one-off or restated earnings can distort it.

Source: filings submitted to the SEC (EDGAR) and delayed market data. Errors or delays are possible; results dates are estimates. Educational only.

Price facts

Latest delayed quote: $443.59, +0.25% versus the previous close (checked at 19:50 UTC on Nov 14, 2026).

Last close: $452.80 on Nov 6, 2026.

52-week closing range: $332.02 to $592.85. The last close sits 46% of the way from the low to the high.

Change over

30 days+9.2%
90 days+19.5%
1 year-19.1%

Recent 3-month volatility is within its usual range compared with its own history since 2021 (47th percentile).

Delayed data. Past moves do not indicate future results.

Create a free account and get 3 AI analyses: reaction zones, macro scenarios and your timeframe.

Try GeekAlpha free: 3 analyses, no card

You're signed in. Open the app to analyze ISRG.

Open the app

Go further on ISRG

What happened

  • Automated summary of the day's move ·

    Down 6.47% on the day. Volume was 1.75 times the 20-day average. The move was 4.83 times its typical volatility.

  • Automated summary of the day's move ·

    Up 1.86% on the day.

Details and limits

From the company filings

Revenue grew on average 17.4% a year over the last 3 fiscal years (FY2022: $6.22B → FY2025: $10.06B).

In the latest quarter (ended Sep 30, 2026) revenue was $3.05B, +21.7% versus the same quarter a year earlier.

Source: company filings on SEC EDGAR, latest filed Oct 21, 2026, data through Sep 30, 2026.

SEC industry classification: Orthopedic, Prosthetic & Surgical Appliances & Supplies. Fiscal year ends December 31. Listed on Nasdaq.

Limits of this information